Skip to main content

Table 6 Baseline characteristics of patients with or without DVT in patients receiving THA

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

  DVT(+) DVT(-) P value
n = 109 n = 759
Age, 75 years 43 (39.4%) 189 (24.9%) 0.001
Female gender 102 (93.6%) 638 (84.1%) 0.009
e-GFR, <60 mL/min per 1.73 m2 17 (15.6%) 102 (13.5%) 0.547
Body mass index, 30 kg/m2 7 (6.4%) 49 (6.5%) 0.981
General anesthesia 83 (76.1%) 666 (87.7%) 0.001
Operation time, 120 minutes 42 (38.5%) 353 (46.5%) 0.118
Use of foot pump 83 (76.1%) 586 (77.2%) 0.806
Use of elastic stocking 95 (87.2%) 697 (91.8%) 0.106
Medications    
  Unfractionated heparin 5 (4.6%) 27 (3.6%) 0.374
  Enoxaparin 17 (15.6%) 131 (17.3%) 0.666
  Fondaparinux 17 (15.6%) 244 (32.1%) <0.0001
  Others 8 (7.3%) 36 (4.7%) 0.248
  1. CI, confidence interval; DVT, deep vein thrombosis; e-GFR, estimated glomerular filtrating ratio; PE, pulmonary embolism; THA, total hip arthroplasty.